MADELINE SLISZ: Open Payments
NPI 1659961076 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$39,213 in 104 payments from 5 companies in 2025. Trend: 2023 $32,023 · 2024 $27,599 · 2025 $39,213
Speaker / faculty: $28,402Consulting: $6,000Food & beverage: $2,614Travel & lodging: $2,007Education: $190
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 35 | $26,285 |
| ACADIA Pharmaceuticals Inc | 28 | $8,468 |
| Teva Pharmaceuticals USA, Inc. | 32 | $4,210 |
| Otsuka America Pharmaceutical, Inc. | 8 | $226 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: INGREZZA, NUPLAZID, UZEDY, AUSTEDO XR, REXULTI, COBENFY.
Industry payments across NY — which companies pay providers there.
